Skip Navigation



NDT Advance Access published online on April 3, 2008

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfn153
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/9/2853    most recent
gfn153v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Massoudy, P.
Right arrow Articles by Herget-Rosenthal, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Massoudy, P.
Right arrow Articles by Herget-Rosenthal, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Coronary artery bypass surgery and acute kidney injury—impact of the off-pump technique

Parwis Massoudy1, Soeren Wagner1, Matthias Thielmann1, Ulf Herold1, Eva Kottenberg-Assenmacher2, Günther Marggraf1, Andreas Kribben3, Thomas Philipp3, Heinz Jakob1 and Stefan Herget-Rosenthal3

1 Department of Thoracic and Cardiovascular Surgery, West German Heart Center Essen 2 Department of Anaesthesiology 3 Department of Nephrology, University Duisburg-Essen, Essen, Germany

Correspondence and offprint requests to: Stefan Herget-Rosenthal, Department of Nephrology, University Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany. Tel: +49-201-723-2552; Fax: +49-201-723-5633; E-mail: stefan.herget-rosenthal{at}uni-due.de



   Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Background. Acute kidney injury (AKI) is a serious and frequent complication after coronary artery bypass grafting (CABG). Cardiopulmonary bypass (CPB) was identified as a major AKI risk factor after CABG. Our aim was to assess the impact of the off-pump coronary artery bypass (OPCAB) compared to the on-pump coronary artery bypass (ONCAB) technique on the rate and severity of AKI, while taking other risk factors for AKI into account.

Methods. An observational study of 201 consecutive adult patients was conducted; 100 were operated by the OPCAB and 101 by the ONCAB technique. All patients in each group were operated by a single, experienced surgeon. Fifteen pre-, intra- and postoperative variables that were repeatedly identified in previous studies as independent AKI risk factors were included in this analysis. AKI was defined as an increase of serum creatinine ≥50% or ≥0.3 mg/dL within 48 h and AKI severity was classified, according to current AKIN definitions.

Results. Significantly fewer OPCAB patients developed AKI compared to ONCAB (14.0 versus 27.7%; P = 0.03). OPCAB was associated with milder stages of AKI, whereas ONCAB patients had more severe AKI. Congestive heart failure and chronic kidney disease were independent risk factors for AKI. The OPCAB technique for CABG was identified as the only independent factor associated with lower incidence of AKI.

Conclusions. Using current AKI definitions and classifications, the OPCAB technique for CABG, which avoids CPB; was associated with a significantly lower rate and less severe AKI compared to ONCAB. The OPCAB technique was identified as the only modifiable and potentially protective factor against postoperative AKI.

Keywords: acute kidney injury; acute renal failure; cardiopulmonary bypass; coronary artery bypass grafting; off-pump coronary artery bypass



   Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Postoperative acute kidney injury (AKI), previously termed acute renal failure, is one of the most serious and frequent complications after coronary artery bypass grafting (CABG) [1–6]. Recent studies demonstrated that even small increases of serum creatinine following CABG are independently associated with increased mortality [2–4,7,8]. As no causal therapy for AKI is available at present, every effort has to be made to prevent AKI. Off-pump coronary artery bypass (OPCAB) grafting, which eliminates the need for cardiopulmonary bypass (CPB), has been reported to be associated with a lower incidence of AKI [9–14]. This issue is still controversial, as other studies did not confirm this finding [15–18]. All studies are limited as they lack a uniform definition of AKI. The definitions of AKI varied widely and were predominately based on large increments of serum creatinine, thus ignoring milder stages of AKI. Furthermore, previous studies analysing the impact of OPCAB on AKI considered only a limited number of variables and especially major postoperative risk factors for AKI were not regarded [3–5,9–13,16,17]. However, this issue is critical, as the CABG technique may be one of the few modifiable risk factors of AKI and the use of OPCAB may in turn aid in reducing postoperative AKI associated with CABG. Recently, a definition and classification of AKI was established by a consensus of all key critical care and nephrology societies worldwide [19]. This first globally developed AKI definition and classification incorporates the important finding that small increases of serum creatinine in AKI already negatively impact outcome.

The purpose of the present study was to assess the impact of the OPCAB technique on the incidence and severity of AKI, firstly applying the current AKI definition and classification and secondly taking into account in our analysis pre-, intra- and postoperative variables that were repeatedly identified as major independent risk factors for AKI.



   Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Patients
In this cohort study, we included 201 of 210 consecutive adult Caucasian patients who underwent isolated CABG of multiple coronary arteries between February and November 2005 by two of eight cardiosurgical consultants in our institution, which is a tertiary referral centre. One hundred patients were operated by the OPCAB and 101 patients by the ONCAB technique. All 201 patients would have been eligible for CABG by either the OPCAB or ONCAB technique. One surgeon performed all OPCAB cases while the other surgeon performed all ONCAB cases. Both surgeons were equally experienced in coronary bypass surgery by the ONCAB technique with only one being proficient in OPCAB surgery. Both surgeons performed all their CABG during the study period exclusively by either the OPCAB or ONCAB technique. The daily operation schedule, which established the order of all surgical procedures and scheduled the surgeons to these procedures, assigned patients to one of the two surgeons and by this means to either the OPCAB or ONCAB technique. Neither of the two surgeons was involved in the planning or fixing of the daily operation schedule. Patient characteristics did not deliberately influence the assignment of patients to the respective surgeon or the CABG technique. Thus, the assignment of study patients to either OPCAB or ONCAB was unregulated and by chance. We excluded patients with end-stage renal disease receiving renal replacement therapy (RRT) (n = 5) and those who were started by OPCAB but were then converted to the ONCAB technique (n = 4).

Anaesthesia, surgery and intensive care treatment
In all patients, anaesthesia was induced with intravenous sufentanil (1 µg/kg), etomidate (50 µg/kg) and pancuronium (100 µg/kg). Anaesthesia was maintained with isoflurane (0.6–1.0%), discontinuously given sufentanil (0.3–0.5 µg/kg) and pancuronium (30 µg/kg). Intraoperatively, all patients received aprotinin (Bayer, Leverkusen, Germany) at a dose of 2.5 million KIU, and intravenous heparin targeted to achieve an activated clotting time of 400 s. At wound closure in OPCAB and after completion of extracorporal circulation in ONCAB, heparin was completely neutralized using protamine (Valeant, Eschborn, Germany) at a dose of 1 mg/100 IU of heparin. In OPCAB patients, distal anastomoses were performed using standard purchasable stabilizers (Ethicon-Cardiovations®, Johnson&Johnson, MO, USA). Nonpulsatile CPB with roller pumps was performed at mild hypothermia (32°C). The CPB circuit was primed with a 1600 mL solution containing lactate Ringer's solution, hydroxyethylstarch, mannitol, sodium bicarbonate and packed red blood cells, if required, to achieve a haemoglobin of at least 8 g/dL during CPB. A minimal flow rate of 2.4 L/m2/min was maintained throughout CPB and the flow rate was adjusted based on haemodynamic parameters and central venous oxygen saturation. During CPB the mean arterial pressure was maintained between 60 and 80 mmHg. A 1000-mL cold cardioplegic solution (Custodiol®, Köhler Chemie, Alsbach-Hähnlein, Germany) was infused through the aortic root to achieve cardioplegia during aortic cross clamping in ONCAB patients. OPCAB surgery was performed at a mean arterial pressure between 70 and 100 mmHg. Deviations beyond this range were corrected with phenylephrine or nitroglyceride.

Postoperatively, all patients were admitted to the intensive care unit (ICU). All were later transferred to the intermediate care unit (IMC) and received standardized treatment, including serum creatinine measurements standardized at least twice daily on ICU and IMC from blood drawn between 7:00 and 8:00 a.m. and p.m., and once between 7:00 and 8:00 a.m., thereafter on regular wards until discharge. Anaesthesia was maintained in all patients with propofol (100 mg/h) for no longer than 24 h postoperatively. When longer anaesthesia was required, propofol was switched to sufentanyl (0.02 mg/h) and midazolam (5 mg/h). Fluid substitution was adjusted to a central venous pressure of 12 mmHg. The target level for the mean arterial pressure was ≥70 mmHg. Crystalloid fluids and inotrops were administered in the case of lower mean arterial pressure according to the specific clinical situation. In the absence of haemorrhage, intravenous heparin was applied for 2 h and 500 mg of intravenous acetylsalicylic acid 4 h after arrival on the ICU. Clinical data were extracted from the patients’ records; laboratory data were retrieved from the hospital electronic laboratory report system. These data were complete for all patients until discharge from hospital or death with the exception of data on interleukin-6 that were available in 34 patients operated by the OPCAB technique and 27 by the ONCAB technique.

AKI definition and classification, and indication for renal replacement therapy
Postoperative AKI and its stages were diagnosed according to the GFR criteria of the current Acute Kidney Injury Network definitions. Information in regard to urine output exactly as required by these definitions was not documented [19]. AKI was diagnosed by an increase of serum creatinine ≥50% or ≥0.3 mg/dL, both from stabile preoperative baseline values and within 48 h. Severity of AKI was classified as stage 1 (serum creatinine increase by 50–100% or ≥0.3 mg/dL), stage 2 (serum creatinine increase by 101–200%) and stage 3 (serum creatinine increase by >200% of the need for RRT). Alternatively, stage 3 was defined by an increase of serum creatinine ≥0.5 mg/dL from baseline serum creatinine values ≥4.0 mg/dL [19]. We performed an analysis of the maximum AKI severity stage reached. RRT in the course of AKI was always initiated when needed, independent of the investigators by a team of eight nephrologists of our institution for the following indications: pulmonary oedema, oliguria defined as urine output <0.5 mL/kg body weight per hour for >6 h, metabolic acidosis or hyperkalaemia not responding to conventional treatment and uraemia defined as urea nitrogen of >100 mg/dL. RRT was available 24 h a day and no patient requiring RRT was denied RRT for futility.

Risk factors of AKI
After a systematic and comprehensive search in MEDLINE, we included all biologically plausible variables that were repeatedly identified in previous studies as major independent risk factors for AKI after CABG [1,3–6,9,13,15–17]. Definitions of variables are presented in Table 1. Definitions for intraoperative acute myocardial infarction, severe sepsis and septic shock are based on previous publications [20–22]. Serum creatinine was measured with an enzymatic colorimetric assay (Crea Plus, Roche Diagnostics, Mannheim, Germany), which is traceable to an isotope dilution mass spectrometry assay [23]. Therefore, the glomerular filtration rate could be estimated according to the simplified, recalculated equation derived from the Modification of Diet in Renal Disease study that is eGFR [mL/min/1.73 m2] = 175 x (serum creatinine [mg/dL])–1.154 x (age [years])–0.203 x (0.742 if female) x (1.212 if African American) [23]. Hospital mortality after CABG was predicted by the EuroSCORE as previously published [24]. The maximum C-reactive protein value within the first 3 days and, when available, the interleukin-6 value within the first 24 h postoperatively were analysed to estimate postoperative systemic inflammatory response.


View this table:
[in this window]
[in a new window]

 
Table 1 Definitions of potential risk factors for acute kidney injury

 
Statistics
Data are reported as mean ± SD unless otherwise indicated. After testing for normal distribution, continuous data were compared by Student's t-test, the Mann–Whitney rank-sum test or the one-way ANOVA on ranks with Dunn's multiple comparison procedure, and categorical data were compared by the Chi square, Fisher's exact test or the Cochran Armitage test of trend. Potential risk factors associated with AKI after CABG were coded as present or absent and assessed by bivariate analysis. Variables with a P <0.05 in bivariate analysis were entered in the multivariate, proportional hazards regression analysis with censoring at the day of discharge from ICU or IMC. Proportional hazards regression analysis was applied to simultaneously adjust for multiple potential risk factors of AKI that were present for differing time periods during admission to ICU and IMC. A two-sided P value <0.05 was considered to be statistically significant. The risk ratio and 95% confidence intervals (95% CI) were calculated based on the model parameter coefficients. Model adequacy was assessed using the goodness-of-fit test by the –2 log likelihood ration. Standardized differences were applied to identify potential imbalances in confounders, and a value >0.10 was considered to indicate imbalances. The local institutional review board approved this study and waved the need for informed consent. The study is in accordance with the declaration of Helsinki.



   Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Pre- and intraoperative characteristics of the 100 patients operated by the OPCAB and the 101 patients operated by the ONCAB technique are shown in Table 2. There were no substantial differences with regard to gender, age, prevalence of diabetes, congestive heart failure and chronic kidney disease, body mass index and preoperative renal function as measured by serum creatinine and estimated glomerular filtration rate. The severity of coronary heart disease did not differ between both cohorts as indicated by similar rates of left main, two- and three-vessel diseases (Table 2). In addition, the predicted postoperative hospital mortality according to the EUROscore was almost identical. Furthermore, small values for standardized differences for most variables emphasize a good balance between both cohorts. Operating times were significantly different as a result of the different surgical techniques.


View this table:
[in this window]
[in a new window]

 
Table 2 Pre- and intraoperative patient data

 
AKI developed in the early postoperative course. Significantly fewer OPCAB patients developed AKI, and OPCAB patients demonstrated a lower maximum serum creatinine postoperatively (Table 3). Whereas patients operated by the OPCAB technique presented predominately with the mildest stage AKI, the majority of those operated by ONCAB had severe forms of AKI. There was also a trend towards less requirement for RRT in OPCAB compared to ONCAB patients. Continuous RRT was the predominant modality in OPCAB (75%) and ONCAB patients (83%) (P = 1.00). RRT was initiated early postoperatively in both OPCAB and ONCAB patients (2.5 ± 1.8 versus 2.0 ± 1.1 days; P = 0.95). Indications for RRT were the following in OPCAB and ONCAB patients, respectively: pulmonary oedema (n = 1 versus 2), oliguria (n = 2 versus 7), hyperkalaemia (n = 1 each) and uraemia (n = 1 each). OPCAB patients demonstrated a substantially lower postoperative systemic inflammatory response indicated by lower C-reactive protein and interleukin-6 levels (Table 3). Combined length of stay in the ICU and IMC, renal function at hospital discharge as indicated by serum creatinine and mortality rate did not differ between patients operated by the OPCAB and ONCAB techniques (Table 3).


View this table:
[in this window]
[in a new window]

 
Table 3 Postoperative renal and general outcome data

 
Patients with AKI demonstrated a markedly enhanced postoperative systemic inflammatory response indicated by higher C-reactive protein and interleukin-6 levels (Table 4). When comparing the four subgroups of OPCAB patients with and without AKI and ONCAB patients with and without AKI, both OPCAB and ONCAB patients with AKI showed higher C-reactive protein (25.9 ± 6.2 versus 17.7 ± 4.8 mg/dL and 30.1 ± 7.9 versus 22.6 ± 6.8 mg/dL; both P <0.05) and interleukin-6 levels (443 ± 221 versus 304 ± 161 pg/mL and 689 ± 412 versus 540 ± 272 pg/mL; both n.s.).


View this table:
[in this window]
[in a new window]

 
Table 4 Characteristics of CABG patients with and without acute kidney injury (AKI)

 
In bivariate analysis, patients with AKI were older, had a higher rate of congestive heart failure and chronic kidney disease, and a higher incidence of postoperative cardiogenic and haemorrhagic shock compared to patients without AKI (Table 4). AKI patients were more often operated by the ONCAB than by the OPCAB technique, stayed in ICU and IMC longer and their renal function at hospital discharge was worse. Two patients operated by the OPCAB technique died having developed AKI from pulmonary failure and haemorrhagic shock, while one patient operated by the ONCAB technique died without AKI from multiorgan failure. A worst-case analysis with the hypothesis of the latter patient having developed AKI would support the findings presented. As demonstrated in Table 5, multiple proportional hazards regression identified preoperative congestive heart failure (HR 3.59, 95% CI 1.86–6.92; P < 0.001) and chronic kidney disease (HR 2.14, 95% CI 1.15–4.00; P = 0.02) as independent risk factors and OPCAB (HR 0.47, 95% CI 0.24–0.92; P = 0.02) as an independent protective factor for AKI. The goodness-of-fit test indicated a good model adequacy with {chi}2 = 27.0 and P < 0.001. Analysing the subgroups of patients with chronic kidney disease and congestive heart failure, OPCAB was also associated with lower incidences of developing AKI compared to the ONCAB technique. Risk ratios were 0.36 (95% CI 0.15–0.88; P = 0.03) for AKI in chronic kidney disease patients with OPCAB and 0.39 (95% CI 0.17–0.93; P = 0.04) for AKI in congestive heart failure patients with OPCAB. Of the four patients who were started by the OPCAB but were then converted to the ONCAB technique, one developed AKI stage 3, requiring RRT.


View this table:
[in this window]
[in a new window]

 
Table 5 Potential risk factors associated with acute kidney injury after coronary artery bypass grafting

 


   Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Our data suggest that the OPCAB technique is an independent, protective factor for AKI in patients undergoing CABG. Considering 15 major pre-, intra- and postoperative risk factors that were repeatedly identified in previous studies, we identified the CABG technique as the only independent modifiable risk factor for AKI in our cohort [1,3–6,9,13,15–17]. This is critical as AKI is a serious and frequent complication after CABG, even minimal acute deteriorations of renal function substantially increase in-hospital and long-term mortality in patients after CABG and no causal therapy for AKI after CABG is presently available [2,3,7,8]. It is thus important to apply strategies that approach modifiable risk factors as the CABG technique to prevent AKI. To reduce the incidence of AKI, CABG using the OPCAB technique may be especially indicated in high-risk subgroups of patients with chronic kidney disease and congestive heart failure, as these were identified as independent, preoperative, non-modifiable risk factors of AKI in the previous and in this study [1,3–6,9,13,15,17], and, according to our results, the AKI rates were lower in these subgroups when they were operated by the OPCAB technique.

The aetiology of AKI after CABG is multifactorial and complex [1]. Besides risk factors for AKI that also apply to other patient populations, AKI can be attributed to the use of CPB. Factors intrinsic to CPB that have been demonstrated to contribute to AKI are aortic cross clamping, low perfusion pressure, non-pulsatile blood flow, the use of centrifugal pumps, haemodilution, use of protamine, generation of emboli, formation of free oxygen radicals and especially the induction of a massive systemic proinflammatory response [1]. These factors result in renal vasoconstriction and microthrombosis, and ischaemic and direct toxic renal injury. Our data confirm that postoperative systemic proinflammatory response is more pronounced in ONCAB than OPCAB and again more in AKI than in patients with preserved renal function. However, our data do not permit us to differentiate the effect of these various factors. Other factors that potentially attenuate the proinflammatory response such as the use of heparin, aprotinine and propofol are unlikely to be effective as they were equally present in both OPCAB and ONCAB patients.

This knowledge about the serious adverse effects of CPB provides the pathophysiological basis for the finding that the avoidance of CPB by the OPCAB technique is associated with an overall lower AKI rate as well as with less severe stages of AKI. However, the protective effect of OPCAB on the incidence of AKI is still controversial. In several recent predominately large studies, OPCAB was associated with a lower risk of developing AKI, whereas some smaller studies did not confirm a beneficial effect of OPCAB on AKI [9–13,16,17]. A recent meta-analysis was also not able to resolve this issue as it demonstrated a reduction of AKI by the OPCAB technique in several, risk-adjusted observational studies with large patient cohorts but not in a smaller number of randomized-controlled studies with a limited number of patients [14]. There are two important causes for these conflicting results. First, previous studies applied widely varying, non-standardized definitions of AKI ranging from small increases of serum creatinine to the requirement of RRT [9–14,16,17]. Secondly, previous studies analysed a limited number of risk factors for AKI and potent postoperative risk factors were not considered [3–5,9–13,16,17].

This study adds to the growing body of evidence of a beneficial effect of OPCAB on AKI as it is, to our knowledge, the first study that applies the current definition and classification of AKI established by a consensus of all key critical care and nephrology societies worldwide, and it incorporates all widely established risk factors for AKI after CABG in its analysis [1,19]. This definition and classification comprises the important finding from recent cardiothoracic surgical studies that small increases of serum creatinine in AKI already have a major impact on outcome, it refines the RIFLE criteria of AKI by including a time limit and an absolute serum creatinine increase in the AKI definition, and it permits comparison of our data with future studies applying this internationally developed and accepted AKI definition [2,3,7,8,19,25]. Thus, the current AKI definition seems optimal to study the effect of OPCAB on AKI. The small increments of serum creatinine that define AKI by this definition fully explain the increased incidence of AKI compared to previous reports with less stringent definitions [4,5]. However, when comparably sensitive definitions are applied similar rates of AKI are observed [2,3,6,9,10,15]. The incidence of AKI in this report is at the head of studies applying RIFLE criteria to define AKI in CABG patients that may be caused by a higher co-morbid disease burden [26–28]. The latter may cause our findings not to be representative for the entire population of patients undergoing CABG. What still makes our findings noteworthy is that high-risk CABG patients are more likely to develop AKI and its associated complications. In addition, there have been two important trends in coronary artery bypass surgery towards older patients with more severe comorbidity and a higher incidence of postoperative AKI [29–31]. Consequently, this study focused on exactly the subpopulation of CABG patients that requires most attention to prevent AKI. The higher rate of RRT for AKI in the present study may arise from more severe AKI and the rather permissive indication for RRT at our institution [4–6,9,10]. Patients with AKI demonstrated a markedly prolonged ICU and IMC stay, which is associated with poorer patient outcome and increased costs [1,26]. This finding suggests an indirect impact of OPCAB on this important postoperative outcome variable and is consistent with a recent report [32]. At the same time, mortality was low with no difference between patients with and without AKI. However, the study was not powered to detect differences in mortality considering OPCAB as a co-factor and this issue must be a subject of future investigation.

This study is limited by its observational, non-randomized design with potential confounding, information and selection bias. However, demographic and clinical characteristics of patients operated by the OPCAB and the ONCAB techniques, especially comorbidity and potential risk factors for AKI, were well balanced. Thus, bias in the assignment of patients to a surgical technique and a confounding effect of these factors on the outcome of the study are hardly likely. Restriction was applied as a strategy to reduce confounding and improve variability. The participation of only two surgeons, with equal experience in CABG, served to reduce surgical variability, which could have biased our results. This is a previously established method in studies comparing OPCAB and ONCAP but may limit generalizability of our results beyond the high-risk cohort that we studied [18]. This implies that our data do not permit us to separately distinguish between the impact of the surgical technique and the impact of the surgeon. The latter may have played a role despite equal experience of both surgeons. Other approaches to reducing confounding were the comprehensive search and inclusion of potential confounders as factors in the statistical analyses. Furthermore, it seems unlikely that confounding by indication, selection or information bias would have had substantial effects on outcome as (i) both cohorts did not differ with respect to disease severity, (ii) patients were assigned to OPCAB or ONCAB by chance, (iii) follow-up data were complete for all patients and worst-case analysis did not alter the results, (iv) potential confounding factors were determined according to definitions and (v) measurement of renal function was identical in all patients, thus inhibiting underestimation of the incidence of AKI. Finally, we performed a single-centre study with a low patient number and our results definitely require validation in a large multicentre study.

In conclusion, our data suggest that the OPCAB technique is an independent, modifiable and protective factor for AKI in patients undergoing CABG when all major pre-, intra- and postoperative risk factors are considered, and AKI is defined by small increases of serum creatinine as currently recommended. Additionally, the OPCAB technique is associated with less severe AKI. Chronic kidney disease and congestive heart failure shock were identified as other independent risk factors of AKI but they are non-modifiable as they are preoperative characteristics. As shown by the present investigation, patients with chronic kidney disease and with chronic heart failure or both may be a particular target population to prevent AKI by performing CABG using the OPCAB technique.



   Acknowledgments
 
The authors are very grateful to Nils Lehmann, Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, for his excellent statistical advice and support.

Conflict of interest statement. None declared.



   References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 

  1. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol (2006) 1:19–36.[Abstract/Free Full Text]
  2. Loef BG, Epema AH, Smilde TD, et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol (2005) 16:195–200.[Abstract/Free Full Text]
  3. Ryckwaert F, Boccara G, Frappier JM, et al. Incidence, risk factors, and prognosis of a moderate increase in plasma creatinine early after cardiac surgery. Crit Care Med (2002) 30:1495–1498.[CrossRef][Web of Science][Medline]
  4. Aronson S, Fontes ML, Miao Y, et al. Risk index for perioperative renal dysfunction/failure. Circulation (2007) 115:733–742.[Abstract/Free Full Text]
  5. Conlon PJ, Stafford-Smith M, White WD, et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant (1999) 14:1158–1162.[Abstract/Free Full Text]
  6. Andersson LG, Ekroth R, Bratteby LE, et al. Acute renal failure after coronary surgery—a study of incidence and risk factors in 2009 consecutive patients. Thorac Cardiovasc Surg (1993) 41:237–241.[Web of Science][Medline]
  7. Lassnigg A, Schmidlin D, Mouhieddine M, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol (2004) 15:1597–1605.[Abstract/Free Full Text]
  8. Brown JR, Cochran RP, Dacey LJ, et al. Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgery. Circulation (2006) 114(Suppl_I):I409–I413.[Web of Science][Medline]
  9. Weerasinghe A, Athanasiou T, Al-Ruzzeh S, et al. Functional renal outcome in on-pump and off-pump coronary revascularisation: a propensity-based analysis. Ann Thorac Surg (2005) 79:1577–1583.[Abstract/Free Full Text]
  10. Hix JK, Thakar CV, Katz EM, et al. Effect of off-pump coronary artery bypass graft surgery on postoperative acute kidney injury and mortality. Crit Care Med (2006) 34:2979–2983.[Web of Science][Medline]
  11. Sajja LR, Mannam G, Chakravarthi RM, et al. Coronary artery bypass grafting with or without cardiopulmonary bypass in patients with preoperative non-dialysis dependent renal insufficiency: a randomized study. J Thorac Cardiovasc Surg (2007) 133:378–388.[Abstract/Free Full Text]
  12. Srinivasan AK, Grayson AD, Fabri BM. On-pump versus off-pump coronary artery bypass grafting in diabetic patients: a propensity score analysis. Ann Thorac Surg (2004) 78:1604–1609.[Abstract/Free Full Text]
  13. Stallwood MI, Grayson AD, Mills K, et al. Acute renal failure in coronary artery bypass surgery: independent effect of cardiopulmonary bypass. Ann Thorac Surg (2004) 77:968–972.[Abstract/Free Full Text]
  14. Wijeysundera DN, Beattie WS, Djaiani G, et al. Off-pump coronary artery surgery for reducing mortality and morbidity: meta-analysis of randomized and observational studies. J Am Coll Cardiol (2005) 46:872–882.[Abstract/Free Full Text]
  15. Chukwuemeka A, Weisel A, Maganti M, et al. Renal dysfunction in high-risk patients after on-pump and off-pump coronary artery bypass surgery: a propensity score analysis. Ann Thorac Surg (2005) 80:2148–2153.[Abstract/Free Full Text]
  16. Schwann NM, Horrow JC, Strong MD, et al. Does off-pump coronary artery bypass reduce the incidence of clinically evident renal dysfunction after multivessel myocardial revascularization. Anesth Analg (2004) 99:959–964.[Abstract/Free Full Text]
  17. Gamoso MG, Phillips-Bute B, Landolfo KP, et al. Off-pump versus on-pump coronary artery bypass surgery and postoperative renal dysfunction. Anesth Analg (2000) 91:1080–1084.[Abstract/Free Full Text]
  18. Puskas JD, Williams WH, Mahoney EM, et al. Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes. JAMA (2004) 291:1841–1849.[Abstract/Free Full Text]
  19. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (2007) 11:R31.[CrossRef][Medline]
  20. Thielmann M, Massoudy P, Schmermund A, et al. Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery. Eur Heart J (2005) 26:2440–2447.[Abstract/Free Full Text]
  21. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med (1992) 20:864–874.[Web of Science][Medline]
  22. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 31:1250–1256.[CrossRef][Web of Science][Medline]
  23. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 145:247–254.[Abstract/Free Full Text]
  24. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19 030 patients. Eur J Cardiothorac Surg (1999) 15:816–823.[Abstract/Free Full Text]
  25. Bagshaw SM, George C, Dinu I, et al. A multi-centre evaluation of the RIFLE criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant (2008) in press.
  26. Dasta JF, Kane-Gill SL, Durtschi AJ, et al. Costs and outcomes of acute kidney injury after cardiac surgery. Nephrol Dial Transplant (2008) in press.
  27. Kuitunen A, Vento A, Suojaranta-Ylinen R, et al. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg (2006) 81:542–546.[Abstract/Free Full Text]
  28. Heringlake M, Knappe M, Vargas Hein O, et al. Renal dysfunction according to the ADQI-RIFLE system and clinical practice patterns after cardiac surgery in Germany. Minerva Anestesiol (2006) 72:645–654.[Web of Science][Medline]
  29. Thakar CV, Worley S, Arrigain S, et al. Improved survival in acute kidney injury after cardiac surgery. Am J Kidney Dis (2007) 50:703–711.[CrossRef][Medline]
  30. Noyez L, Janssen DP, Van Druten JA, et al. Coronary bypass surgery: what is changing? Analysis of 3834 patients undergoing primary isolated myocardial revascularization. Eur J Cardiothorac Surg (1998) 13:365–369.[CrossRef][Web of Science][Medline]
  31. Abramov D, Tamariz MG, Fremes SE, et al. Trends in coronary artery bypass surgery results: a recent, 9-year study. Ann Thorac Surg (2000) 70:84–90.[Abstract/Free Full Text]
  32. Bucerius J, Gummert JF, Walther T, et al. Predictors of prolonged ICU stay after on-pump versus off-pump coronary artery bypass grafting. Intensive Care Med (2004) 30:88–95.[CrossRef][Web of Science][Medline]
Received for publication: 21.10.07
Accepted in revised form: 26. 2.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Elahi, S. Asopa, A. Pflueger, N. Hakim, and B. Matata
Acute kidney injury following cardiac surgery: impact of early versus late haemofiltration on morbidity and mortality
Eur. J. Cardiothorac. Surg., May 1, 2009; 35(5): 854 - 863.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/9/2853    most recent
gfn153v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Massoudy, P.
Right arrow Articles by Herget-Rosenthal, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Massoudy, P.
Right arrow Articles by Herget-Rosenthal, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?